Artemis Medicare Services Limited

NSEI:ARTEMISMED Stock Report

Market Cap: ₹44.1b

Artemis Medicare Services Valuation

Is ARTEMISMED undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ARTEMISMED when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ARTEMISMED (₹320.2) is trading below our estimate of fair value (₹490.41)

Significantly Below Fair Value: ARTEMISMED is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ARTEMISMED?

Key metric: As ARTEMISMED is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ARTEMISMED. This is calculated by dividing ARTEMISMED's market cap by their current earnings.
What is ARTEMISMED's PE Ratio?
PE Ratio68.1x
Earnings₹646.58m
Market Cap₹44.06b

Price to Earnings Ratio vs Peers

How does ARTEMISMED's PE Ratio compare to its peers?

The above table shows the PE ratio for ARTEMISMED vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average52.8x
INDRAMEDCO Indraprastha Medical
25.8xn/a₹38.1b
523323 Kovai Medical Center and Hospital
28.6xn/a₹57.7b
HCG HealthCare Global Enterprises
114.4x48.2%₹65.3b
SHALBY Shalby
42.4x59.6%₹23.2b
ARTEMISMED Artemis Medicare Services
68.1x35.1%₹44.1b

Price-To-Earnings vs Peers: ARTEMISMED is expensive based on its Price-To-Earnings Ratio (68.1x) compared to the peer average (52.8x).

Price to Earnings Ratio vs Industry

How does ARTEMISMED's PE Ratio compare vs other companies in the IN Healthcare Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.1xn/aUS$11.77m
542918 Gian Life Care
4.8xn/aUS$2.28m
No more companies available in this PE range
ARTEMISMED 68.1xIndustry Avg. 42.6xNo. of Companies6PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ARTEMISMED is expensive based on its Price-To-Earnings Ratio (68.1x) compared to the Indian Healthcare industry average (42.6x).

Price to Earnings Ratio vs Fair Ratio

What is ARTEMISMED's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ARTEMISMED PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio68.1x
Fair PE Ratio70.1x

Price-To-Earnings vs Fair Ratio: ARTEMISMED is good value based on its Price-To-Earnings Ratio (68.1x) compared to the estimated Fair Price-To-Earnings Ratio (70.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ARTEMISMED forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹320.20
₹321.00
+0.2%
5.9%₹340.00₹302.00n/a2
Nov ’25₹279.45
₹331.00
+18.4%
8.8%₹360.00₹302.00n/a2
Oct ’25₹284.55
₹331.00
+16.3%
8.8%₹360.00₹302.00n/a2
Sep ’25₹286.05
₹331.00
+15.7%
8.8%₹360.00₹302.00n/a2

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Medico Intercontinental

₹557.2m

Trades in pharmaceutical products.

539938

₹61.29

7D

33.1%

1Y

-27.8%

Dr Lalchandani Labs

₹81.2m

Provides diagnostic and related healthcare tests and services in India.

541299

₹18.73

7D

4.1%

1Y

-46.5%

N G Industries

₹566.9m

Provides various healthcare services in India.

530897

₹168.05

7D

0.2%

1Y

2.7%